Literature DB >> 9142124

Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice.

M D Iafrati1, R H Karas, M Aronovitz, S Kim, T R Sullivan, D B Lubahn, T F O'Donnell, K S Korach, M E Mendelsohn.   

Abstract

The atheroprotective effects of estrogen in women are well recognized, but the underlying mechanisms responsible are not well understood. Blood vessel cells express the classic estrogen receptor, ER alpha (ref. 2-6), and are directly affected by estrogen, which inhibits the development of atherosclerotic and injury-induced vascular lesions. We have generated mice in which the ER alpha gene is disrupted and have used a mouse model of carotid arterial injury to compare the effects of estrogen on wild-type and estrogen receptor-deficient mice. Increases in vascular medial area and smooth muscle cell proliferation were quantified following vascular injury in ovariectomized mice treated with vehicle or with physiologic levels of 17 beta-estradiol. Surprisingly, in both wild-type and estrogen receptor-deficient mice, 17 beta-estradiol markedly inhibited to the same degree all measures of vascular injury. These data demonstrate that estrogen inhibits vascular by a novel mechanism that is independent of the classic estrogen receptor, ER alpha.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9142124     DOI: 10.1038/nm0597-545

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  76 in total

Review 1.  Estrogen receptor and the SERM concept.

Authors:  G G Kuiper; G J van den Bemd; J P van Leeuwen
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

Review 2.  Molecular mechanisms of estrogen actions on the vasculature.

Authors:  M P Haynes; K S Russell; J R Bender
Journal:  J Nucl Cardiol       Date:  2000 Sep-Oct       Impact factor: 5.952

3.  Placental growth factor mediates aldosterone-dependent vascular injury in mice.

Authors:  Iris Z Jaffe; Brenna G Newfell; Mark Aronovitz; Najwa N Mohammad; Adam P McGraw; Roger E Perreault; Peter Carmeliet; Afshin Ehsan; Michael E Mendelsohn
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

4.  DT56a stimulates creatine kinase specific activity in vascular tissues of rats.

Authors:  D Somjen; I Yoles
Journal:  J Endocrinol Invest       Date:  2003-10       Impact factor: 4.256

Review 5.  Estrogen receptors: structure, mechanisms and function.

Authors:  Sylvia Curtis Hewitt; Kenneth S Korach
Journal:  Rev Endocr Metab Disord       Date:  2002-09       Impact factor: 6.514

6.  Increased estrogen receptor alpha in experimental aortic aneurysms in females compared with males.

Authors:  Adriana Laser; Abhijit Ghosh; Karen Roelofs; Omar Sadiq; Brendan McEvoy; Paul DiMusto; Jon Eliason; Gilbert R Upchurch
Journal:  J Surg Res       Date:  2013-08-18       Impact factor: 2.192

7.  Specific association of estrogen receptor beta with the cell cycle spindle assembly checkpoint protein, MAD2.

Authors:  G Poelzl; Y Kasai; N Mochizuki; P W Shaul; M Brown; M E Mendelsohn
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

Review 8.  The role of estrogen and receptor agonists in maintaining organ function after trauma-hemorrhage.

Authors:  Huang-Ping Yu; Irshad H Chaudry
Journal:  Shock       Date:  2009-03       Impact factor: 3.454

9.  17 Beta-estradiol differentially affects left ventricular and cardiomyocyte hypertrophy following myocardial infarction and pressure overload.

Authors:  Richard D Patten; Isaac Pourati; Mark J Aronovitz; Alawi Alsheikh-Ali; Sarah Eder; Thomas Force; Michael E Mendelsohn; Richard H Karas
Journal:  J Card Fail       Date:  2008-04       Impact factor: 5.712

10.  The transactivating function 1 of estrogen receptor alpha is dispensable for the vasculoprotective actions of 17beta-estradiol.

Authors:  Audrey Billon-Galés; Coralie Fontaine; Cédric Filipe; Victorine Douin-Echinard; Marie-José Fouque; Gilles Flouriot; Pierre Gourdy; Françoise Lenfant; Henrik Laurell; Andrée Krust; Pierre Chambon; Jean-François Arnal
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.